Greg Lucier

Invitrogen’s board approved a 7-percent raise for CEO Greg Lucier, the company said in a document filed with the US Securities and Exchange Commission this week. Lucier’s new base salary is $975,000 effective Feb. 27 and retroactive to Jan. 1. In 2007, Lucier’s base salary was $910,000, according to a separate SEC filing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.